Ignite Creation Date:
2024-05-06 @ 3:10 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04542785
Status:
RECRUITING
Last Update Posted:
2022-03-16
First Post:
2020-08-26
Brief Title:
Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation The Danish Atrial Fibrillation Randomised Clinical Trial
Sponsor:
Holbaek Sygehus
Organization:
Holbaek Sygehus
Study Overview
Official Title:
Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation The Danish Atrial Fibrillation DanAF Randomised Clinical Trial
Status:
RECRUITING
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DanAF
Brief Summary:
Atrial fibrillation is the most common heart arrhythmia with a prevalence of approximately 2 in the western world Atrial fibrillation is associated with an increased risk of death and morbidity The comparable effects of a lenient rate control strategy and a strict rate control strategy in patients with atrial fibrillation are uncertain and only one trial has assessed this previously in patients with permanent atrial fibrillation
The investigators will therefore undertake a randomised superiority trial at four hospitals in Denmark
The investigators will therefore undertake a randomised superiority trial at four hospitals in Denmark
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None